155 related articles for article (PubMed ID: 12694540)
1. Presence of Gal-alpha1,3Gal epitope on xenogeneic lines: implications for cellular gene therapy based on the encapsulation technology.
Déglon N; Aubert V; Spertini F; Winkel L; Aebischer P
Xenotransplantation; 2003 May; 10(3):204-13. PubMed ID: 12694540
[TBL] [Abstract][Full Text] [Related]
2. Removal of xenoreactive human anti-pig antibodies by absorption on recombinant mucin-containing glycoproteins carrying the Gal alpha1,3Gal epitope.
Liu J; Qian Y; Holgersson J
Transplantation; 1997 Jun; 63(11):1673-82. PubMed ID: 9197365
[TBL] [Abstract][Full Text] [Related]
3. Reduction in the level of Gal(alpha1,3)Gal in transgenic mice and pigs by the expression of an alpha(1,2)fucosyltransferase.
Sharma A; Okabe J; Birch P; McClellan SB; Martin MJ; Platt JL; Logan JS
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7190-5. PubMed ID: 8692967
[TBL] [Abstract][Full Text] [Related]
4. Intracellular expression in pig cells of anti-alpha1,3galactosyltransferase single-chain FV antibodies reduces Gal alpha1,3Gal expression and inhibits cytotoxicity mediated by anti-Gal xenoantibodies.
Vanhove B; Charreau B; Cassard A; Pourcel C; Soulillou JP
Transplantation; 1998 Dec; 66(11):1477-85. PubMed ID: 9869089
[TBL] [Abstract][Full Text] [Related]
5. Natural anti-galactose alpha1,3 galactose antibodies delay, but do not prevent the acceptance of extracellular matrix xenografts.
Raeder RH; Badylak SF; Sheehan C; Kallakury B; Metzger DW
Transpl Immunol; 2002 Jun; 10(1):15-24. PubMed ID: 12182460
[TBL] [Abstract][Full Text] [Related]
6. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
7. Alpha-galactosyl epitope-mediated activation of porcine aortic endothelial cells: type II activation.
Palmetshofer A; Galili U; Dalmasso AP; Robson SC; Bach FH
Transplantation; 1998 Apr; 65(7):971-8. PubMed ID: 9565103
[TBL] [Abstract][Full Text] [Related]
8. Resistance to anti-xenogeneic response by combining alpha-Gal silencing with HO-1 upregulation.
Zhu M; Zhang W; Liu F; Wang L; Liu B; Chen D; Zhu XH; Zhang WJ; Ichim TE; Chen ZS; Zhou P; Chen S; Chen G
Transpl Immunol; 2008 Jul; 19(3-4):202-8. PubMed ID: 18598766
[TBL] [Abstract][Full Text] [Related]
9. Intact pig pancreatic islet function in the presence of human xenoreactive natural antibody binding and complement activation.
Mirenda V; Le Mauff B; Cassard A; Huvelin JM; Boeffard F; Faivre A; Soulillou JP; Anegon I
Transplantation; 1997 May; 63(10):1452-62. PubMed ID: 9175810
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-mediated expression of human secretor type alpha(1,2) fucosyltransferase reduces level of Gal alpha(1,3)Gal epitope.
Xing L; Xia GH; Fei J; Bai XF; Guo LH
Acta Pharmacol Sin; 2000 Sep; 21(9):807-13. PubMed ID: 11501162
[TBL] [Abstract][Full Text] [Related]
11. In Contrast to Anti-C5 Therapy, Cobra Venom Factor Does Not Prevent Rejection of Xenogeneic Cartilage in Mice.
Brokaw JL; Costa C
Transplant Proc; 2015 Oct; 47(8):2397-9. PubMed ID: 26518939
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of xenogeneic response in porcine endothelium using RNA interference.
Zhu M; Wang SS; Xia ZX; Cao RH; Chen D; Huang YB; Liu B; Chen ZK; Chen S
Transplantation; 2005 Feb; 79(3):289-96. PubMed ID: 15699758
[TBL] [Abstract][Full Text] [Related]
13. Expression of human alpha-galactosidase and alpha1,2-fucosyltransferase genes modifies the cell surface Galalpha1,3Gal antigen and confers resistance to human serum-mediated cytolysis.
Jia Y; Ren H; Gao X; Ji S; Yang J; Liu Z; Li S; Zhang Y
Chin Med Sci J; 2004 Mar; 19(1):31-7. PubMed ID: 15104222
[TBL] [Abstract][Full Text] [Related]
14. Trichostatin A-Assisted Epigenomic Modulation Affects the Expression Profiles of Not Only Recombinant Human α1,2-Fucosyltransferase and α-Galactosidase A Enzymes But Also Galα1→3Gal Epitopes in Porcine Bi-Transgenic Adult Cutaneous Fibroblast Cells.
Wiater J; Samiec M; Skrzyszowska M; Lipiński D
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573215
[TBL] [Abstract][Full Text] [Related]
15. Retroviral vector producer cell killing in human serum is mediated by natural antibody and complement: strategies for evading the humoral immune response.
Rollins SA; Birks CW; Setter E; Squinto SP; Rother RP
Hum Gene Ther; 1996 Mar; 7(5):619-26. PubMed ID: 8845387
[TBL] [Abstract][Full Text] [Related]
16. Transgenic expression of human alpha1,2-fucosyltransferase (H-transferase) prolongs mouse heart survival in an ex vivo model of xenograft rejection.
Chen CG; Salvaris EJ; Romanella M; Aminian A; Katerelos M; Fisicaro N; d'Apice AJ; Pearse MJ
Transplantation; 1998 Mar; 65(6):832-7. PubMed ID: 9539096
[TBL] [Abstract][Full Text] [Related]
17. alpha1,3-Galactosyltransferase gene-knockout miniature swine produce natural cytotoxic anti-Gal antibodies.
Dor FJ; Tseng YL; Cheng J; Moran K; Sanderson TM; Lancos CJ; Shimizu A; Yamada K; Awwad M; Sachs DH; Hawley RJ; Schuurman HJ; Cooper DK
Transplantation; 2004 Jul; 78(1):15-20. PubMed ID: 15257033
[TBL] [Abstract][Full Text] [Related]
18. Human natural killer lymphocytes directly recognize evolutionarily conserved oligosaccharide ligands expressed by xenogeneic tissues.
Inverardi L; Clissi B; Stolzer AL; Bender JR; Sandrin MS; Pardi R
Transplantation; 1997 May; 63(9):1318-30. PubMed ID: 9158028
[TBL] [Abstract][Full Text] [Related]
19. Anti-galactose-alpha(1,3) galactose antibody production in alpha1,3-galactosyltransferase gene knockout mice after xeno and allo transplantation.
Chong A; Blinder L; Ma L; Yin D; Shen J; Williams JW; Byrne G; Schwarz A; Diamond LS; Logan JE
Transpl Immunol; 2000 Jun; 8(2):129-37. PubMed ID: 11005319
[TBL] [Abstract][Full Text] [Related]
20. Xenogeneic thyroid-stimulating hormone-like activity of the human natural anti-Gal antibody. Interaction of anti-Gal with porcine thyrocytes and with recombinant human thyroid-stimulating hormone receptors expressed on mouse cells.
Winand RJ; Anaraki F; Etienne-Decerf J; Galili U
J Immunol; 1993 Oct; 151(7):3923-34. PubMed ID: 8104224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
